Presentation is loading. Please wait.

Presentation is loading. Please wait.

KDDF Pipeline (’13.7) Discovery (18) Pre-Clinical (6) Phase1 (6)

Similar presentations


Presentation on theme: "KDDF Pipeline (’13.7) Discovery (18) Pre-Clinical (6) Phase1 (6)"— Presentation transcript:

1 KDDF Pipeline (’13.7) Discovery (18) Pre-Clinical (6) Phase1 (6)
Oncology (9) CV (5) 진 행 과 제 (26) Metabolic Disease (4) CNS (5) 한림대 –서홍원 UKN target, Neuropathic Pain Infection (4) Immunology (3) 고려대-김윤기 NMD, 듀센병 치료제 GI (1) Others (2) 이언메딕스 황색포도구균 백신 Total : (33) SKAI Anti-angiogenic antibody 서울대 -주건 miR-206, Alzheimer 신풍 Cardiac myosin activator, 강심제 큐리언트 (Q203) Cyt-bc1 complex, MDR/XDR-TB Licensing-Out (3) 상위단계 진입 (4) KIST Triple reuptake inhibitor,우울증 강원대 -홍효정 L1CAM mAb,담도암 종근당 (CKD-519) CETP inhibitor, Dyslipidemia LG생명 (LC ) Mitochondria-ROS, MI 중앙대-민경훈 EGFR T790M, NSCLC 다이노나 MD-3 antibody, 동종췌도이식 레고켐 (LCB ) G(-) antibiotics 파맵신 (tanibirumab) VEGFR-2 항체치료제, 뇌암 SKBP (YKP10811) 5-HT4-변비/IBS 한올 IgGRIII, 중증자가면역질환 충남대-김은희 RIPK1, 실명질환 신풍 (SP-35454) TAZ inhibitor, 골다공증 녹십자 (GCC-4401C) Factor Xa, 항응혈제 한미 (HM11260C) GLP-1, 당뇨 덕성여대-문애리 Flotillin-1, 유방암 KRIBB E2-EPF UCP inhibitor, 간암 제넥신 (인성장호르몬) 레고켐 (LCB ) 옥사졸리디논계 항생제 SKBP (YKP3089) 간질 Discovery (18) 선도 선도(11) 후보(7) Pre-Clinical (6) Phase1 (6) Phase2 (3) 종료과제 (7) 충남대-정상헌 Cardiac myosin activator, 강심제 네오팜 (NPS-1034) C-MET/AXL kinase inhibitor,종양 오스코텍 (SKI-O-282) Spleen TK, RA 부광 (YN968D1) VEGFR-2, 고형암 한미 GPR119, 당뇨 대웅제약 (DWP09031) Aβ inhibitor, Alzheimer 유아이 (UAI-201) B-Raf 표적항암제, 흑색종


Download ppt "KDDF Pipeline (’13.7) Discovery (18) Pre-Clinical (6) Phase1 (6)"

Similar presentations


Ads by Google